marker for determination of sensitivity for anticancer agent in triple combination

• 收藏
• 分享

专利权人:

KABUSHIKI KAISHA YAKULT HONSHA

发明人:

HIDETAKA EGUCHI,MASAHIKO NISHIYAMA,SATORU WADA

申请号：

BR112013013656

公开号：

BR112013013656A2

申请日:

2011.12.02

申请国别(地区):

BR

年份:

2016

代理人:

摘要：

To provide a marker for determining sensitivity of a patient to an anti-cancer agent, which marker can determine whether or not the patient has a therapeutic response to the anti-cancer agent, and novel cancer therapeutic means employing the marker. The marker for determining the sensitivity of a subject to an anti-cancer agent including oxaliplatin or a salt thereof, fluorouracil or a salt thereof, and levofolinate or a salt thereof, the marker containing one or more genes selected from the group consisting of ALAD gene, C20orf43 gene, CABLES1 gene, CDC14B gene, GDA gene, HOXB6 gene, RPL7AP27 gene, TMEM18 gene, and UGT2B10 gene.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/